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Purpose: We retrospectively analyzed open pulmonary
thromboembolectomy in patients with acute and chronic
pulmonary thromboembolism. Materials and Methods: Between
August 1990 and May 2005, 12 consecutive patients with
acute and chronic pulmonary thromboembolism underwent
open pulmonary thromboembolectomy at Yonsei Cardiovas-
cular Center. Their mean age was 47.5 years, and 7 of the
patients were female. Among 12 patients, 5 had acute onset,
and 7 had chronic disease, and 9 patients were associated with
deep venous thrombosis. Extent of pulmonary embolism was
massive in 3 patients with hemodynamic instability, and sub-
massive in 8 patients. Preoperative echocardiogram revealed
elevated right ventricular pressure in all patients, and 7
patients were in NYHA functional class III or IV. Pulmonary
thromboembolectomy was performed in all patients under total
circulatory arrest. Results: There were 2 hospital deaths (16.7%).
Among the patients who survived, mean right ventricular
pressure was decreased significantly from 64.3 mmHg to 34.0
mmHg with improvement of NYHA functional class.
Conclusion: Open pulmonary thromboembolectomy is thought
to be an immediate and definitive treatment for massive pul-
monary embolism with optimal results. Even though operative
mortality is still high, early diagnosis and immediate surgical
intervention in highly selective patients may improve the
clinical outcome.
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INTRODUCTION
Pulmonary thromboembolism is an increasing
disease entity with still advanced mortality and
high recurrence rates. In most of patients, conser-
vative anticoagulation therapy is effective; however,
massive pulmonary embolism with cardiovascular
collapse, indicating significant obstruction of major
pulmonary vasculature, has a very poor prognosis,
and sufficiently treat these patients has been a
challenge. In this study, we evaluated the clinical
outcome of 12 consecutive patients with massive
or submassive pulmonary thromboembolism who
were surgically treated.
MATERIALS AND METHODS
From August 1990 to May 2005, 12 patients
underwent pulmonary thromboembolectomy at
Yonsei Cardiovascular Center. Hospital records of
all patients who underwent open pulmonary
thromboembolectomy were retrospectively re-
viewed. There were 5 men, and 7 women, and their
mean age at the time of operation was 47.5 years
(range: 30 - 65 years). Among 12 patients, 5 had
acute onset, and 7 had chronic disease, and 9
patients were associated with prior or concurrent
deep venous thrombosis of lower extremity. Other
associated disease included anti-phospholipid
antibody syndrome in 3 patients, sticky platelet
syndrome in 1 patient, and protein C deficiency
in 1 patient (Table 1). Three patients had massive
pulmonary embolism, and 9 had submassive pul-
monary embolism. Massive pulmonary embolism
was diagnosed in patients with shock or hypo-
tension (defined as systolic blood pressure less
than 90mmHg or a decrease of more than 40
mmHg over 15 minutes if not caused by new-onset
arrhythmia, hypovolemia, or sepsis), and submas-
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sive pulmonary embolism was identified by the
echocardiographic finding of right ventricular dys-
function without hemodynamic instability.
1,2 All
patients had 1 or more symptoms suggestive of
pulmonary embolism such as dyspnea, pleuritic
chest pain, syncope, dizziness, cough, and hypoxia.
Two patients required intubation prior to surgery.
The indication of surgery was acute hemodynamic
or respiratory compromise or chronic symptomatic
patients with a major pulmonary embolism, and
pulmonary hypertension. The diagnosis and extend
of the disease was made by chest computed tomo-
gram (CT), and transthoracic echocardiogram
(TTE) was also performed in all patients to evaluate
right and left ventricular function, right ventricular
pressure, and association of other intracardiac
disease. One patient with acute massive pul-
monary thromboembolism preoperatively suffered
from cardiac arrest, requiring cardiopulmonary
resuscitation. All but 2 patients had perioperative
placement of an inferior vena caval (IVC) filter. In
all survivors, anticoagulation by means of war-
farin sodium was started on postoperative day 1
to maintain international normalized ratio (INR) of
1.5 - 2.0. Postoperative anticoagulation was main-
tained after surgery for 6 months to 1 year, and
changed to low dose aspirin afterwards.
Surgical technique
Through a classical median sternotomy ap-
proach, vertical pericardiotomy was performed,
and conventional cardiopulmonary bypass was
initiated after systemic heparinization. The arterial
cannula was placed in the ascending aorta and
bicaval venous cannula was placed through the
right atrium. The procedure was performed with
aortic cross-clamping, cold blood cardioplegia, and
deep hypothermia with intermittent periods of
circulatory arrest. A transverse arteriotomy was
made in the pulmonary trunk to the left main
pulmonary artery, and another incision was se-
quentially made in the right main pulmonary
artery, and the fresh and organized thrombi were
gently extracted as distal as possible. The lungs
were manually compressed to mobilize the peri-
pheral clots. Rewarming the patients, the pulmo-
nary arteries were repaired. Weaning from the
cardiopulmonary bypass was successfully per-
formed in all patients.




Sex Symptoms Risk factors Extent of disease Operative findings Mortality
1 54 F Dyspnea, cough DVT, sticky plt Sd Submassive Bilateral PA No
2 56 M Chest pain DVT Submassive Bilateral PA No
3 43 F Dyspnea DVT, ptn C def Submassive Main, bilateral PA No
4 46 M Dyspnea DVT, anti-PL Ab Submassive Main, bilateral PA No
5 30 F Dyspnea, dizziness DVT Submassive Main, bilateral PA No
6 48 F Dyspnea, syncope DVT Massive Main, left PA No
7 61 F Dyspnea, facial edema Anti-PL Ab Submassive Multiple lobar PA No
8 33 M Dyspnea DVT Massive RA, bilateral PA No
9 45 F Syncope, hypoxia DVT, anti-PL Ab Massive Main, bilateral PA Yes
10 65 M Dyspnea DVT Submassive Bilateral PA Yes
11 46 F Chest pain Submassive Main, bilateral PA No
12 43 M Dyspnea Submassive Multiple lobar PA No
F, female; M, male; DVT, deep venous thrombosis; Sticky plt Sd, sticky platelet syndrome; Anti-PL Ab, anti-phospholipid antibody
syndrome; PA, pulmonary artery; RA, right atrium.Open Pulmonary Thromboembolectomy
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RESULTS
All patients had large central emboli in the right
and/or left pulmonary artery. All patients had
moderate or severe right ventricular dysfunction,
identified by intraoperative trans-esophageal echo-
cardiogram (TEE). Mean cardiopulmonary bypass
and aortic clamp time were 239.8 ± 43.8 minutes
(range, 189 - 291 minutes), and 131.8 ± 40.8 minutes
(range, 88 - 174 minutes), respectively. Mean total
circulatory arrest time was 47.4 ± 27.8 minutes
(range, 16 - 88 minutes) with lowering mean body
temperature to 19.9 ± 2.8°C (range, 17 - 25°C). Mean
duration of ventilator care and ICU stay were 1.7
±0.9 days (range, 1-3 days), and 4 ±2.6 days (range,
2 - 9 days), respectively. Three of the 12 patients
underwent concomitant cardiac surgical proce-
dures: one had a repair of foramen ovale, another
patient had an excision of right atrial thrombi, and
the other patient had a tricuspid annuloplasty.
Seven of the 12 patients required postoperative in-
otropic support by means of dobutamine, or
milrinone for mean of 5 ± 4.9 days (range, 1 - 15
days). Mean hospital stay was 15.7 ±5.6 days (range,
9 - 25 days).
There were two hospital deaths (16.7%) on post-
operative day 5, and 15, respectively. One of the
patients had massive pulmonary embolism with
unstable hemodynamics which required preopera-
tive ventilator care as well as inotropic support,
and underwent urgent operation. The patient's
preoperative central venous pressure patient was
28 mmHg and, even though cardiopulmonary
bypass weaning was successfully performed, re-
perfusion pulmonary edema developed on im-
mediate postoperative period and eventually died.
The other patient had elective operation for
submassive pulmonary embolism, and postopera-
tive course was relatively uneventful. However,
sudden massive endobronchial bleeding occurred
during weaning from mechanical ventilator and
died.
For all survivors, postoperative echocardiogram
was performed before discharge. Postoperative
mean right ventricular pressure was decreased
significantly from 64.3 ± 19.2 mmHg (range, 45 -
104 mmHg) to 34.0 ± 11.3 mmHg (range, 25 - 54
mmHg) (p = 0.002). Mean NYHA functional class
also significantly improved from 3.1 ± 0.9 (range,
2 - 4) to 1.4 ± 0.5 (range, 1 - 2) (p= 0.0001). Localized
reperfusion injury was documented on chest X-ray,
taken during postoperative period, in three patients
that was resolved before discharge.
Follow-up was completed in all survivors (n =
10) for mean duration of 40.4 ± 9.0 months (range,
24.9 - 58.0 months), and there was no recurrence
of pulmonary thromboembolism during follow up
period.
DISCUSSION
Despite the current emphasis on deep venous
thrombosis prophylaxis, the prevalence of pulmo-
nary embolism in hospitalized patients is around
1%.
3 Severe pulmonary embolism is associated
with a high mortality rate, due to acute right heart
failure, and hypoxia despite advances in diagnosis
and therapy.
4-6 Open pulmonary embolectomy,
previously thought to be a treatment of last resort,
has recently been encouraged for patients with
severe pulmonary embolism.
7-9 Thrombolytic the-
rapy and catheter-based transvenous thromboem-
bolectomy have been proven effective in patients
with acute massive pulmonary embolism.
10-14
However, these treatment modalities are also asso-
ciated with an increased risk of hemorrhage, recur-
rent pulmonary embolism, and failure to com-
pletely resolve the intraluminal thrombus, even-
tually resulting in pulmonary hypertension.
9,10,15,16
Therefore, pulmonary embolectomy is suggested
for selected highly compromised patients who are
unable to receive thrombolytic therapy or whose
critical status does not allow sufficient time to
infuse thrombolytic agents.
17
The most frequent indication for pulmonary
embolectomy is hemodynamic instability despite
heparin therapy and resuscitative efforts, which is
reported as high as 74%.
17 Other indications include
cardiac arrest, contraindications to or failure of
thrombolytic therapy.
17,18 On the other hands, the
only absolute contraindication to thromboendar-
terectomy is the presence of severe underlying lung
disease, either obstructive or restrictive. Advanced
age, severe right ventricular failure, and the pre-
sence of collateral disease influence the risk assess-
ment, however, they are not absolute contraindi-
cation.
19 In this study, patients with acute pulmo-Sak Lee, et al.
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nary embolism underwent urgent or emergent
embolectomy due to hemodynamic instability, and
patients with chronic pulmonary embolism under-
went elective embolectomy mainly due to severe
symptoms of congestive heart failure or pulmo-
nary hypertension. Despite poor preoperative
condition in these patients, we were able to perform
successful open pulmonary embolectomy in all
patients using conventional cardiopulmonary
bypass. Use of femoral artery and venous bypass
by the means of percutaneous cardiopulmonary
support (PCPS) has also been reported as an
alternative to conventional cannulation in unstable
patients,
20 which was not required in our patients.
The placement of IVC filter in patients who
undergo pulmonary embolectomy is well sup-
ported by several studies.
21-23 Decousus et al.
21
demonstrated in their randomized study of 400
patients with DVT that, placement of an IVC filter
was associated with 1% rate of pulmonary emboli-
sm, whereas patients without IVC filter placement
had 5% pulmonary embolism rate within the first
12 days, and Rosenberger et al.
22 also reported that
recurrent pulmonary embolism can occur early
after pulmonary embolectomy even in the presence
of coagulopathy, and therefore, concurrent IVC
filter placement should be considered during or
immediately after pulmonary embolectomy to pre-
vent recurrent pulmonary embolism. Our institute
has a policy to place IVC filter on a routine basis
in patients with deep venous thrombosis, as well
as patients who are scheduled for pulmonary
thromboembolectomy. In this study, we failed to
insert IVC filter in 2 patients: 1 patient refused the
procedure, who survived without a recurrence,
and the other patient underwent urgent operation
and died postoperative day 5, and there was no
time for IVC filter placement.
A mortality of 16.7% after open pulmonary
thromboemboletomy is still high, but close to that
observed in previous reports (11 - 35%).
24-27 To im-
prove the outcome, early diagnosis through reason-
able clinical suspicion of pulmonary thromboem-
bolism, rapid treatment, and careful patient selec-
tion all should preceded.
In conclusion, open pulmonary thromboembo-
lectomy is thought to be an immediate and defini-
tive treatment for massive pulmonary embolism
with optimal results. Even though the operative
mortality is still high, early diagnosis and immedi-
ate surgical intervention in highly selective patients
may improve the clinical outcome.
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